# Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine

> **NCT01148017** · PHASE3 · COMPLETED · sponsor: **Novartis Vaccines** · enrollment: 433 (actual)

## Conditions studied

- Meningococcal Meningitis

## Interventions

- **BIOLOGICAL:** Meningococcal (groups A, C, W, and Y) oligosaccharide diphtheria CRM-197 conjugate vaccine

## Key facts

- **NCT ID:** NCT01148017
- **Lead sponsor:** Novartis Vaccines
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 433 (ACTUAL)
- **Last updated:** 2017-08-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01148017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01148017, "Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01148017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*